We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




AI Powered Mini-Camera Predicts Recurrent Heart Attack

By HospiMedica International staff writers
Posted on 03 Sep 2025

A heart attack occurs when a coronary artery becomes blocked, cutting off oxygen supply to the heart. More...

Treatment usually involves angioplasty with stent placement, a procedure performed around 40,000 times annually in the Netherlands. Despite intervention, about 15% of patients experience another heart attack within two years. Now, a new approach combines imaging and artificial intelligence (AI) to identify weak arterial spots that could trigger recurrent events.

Researchers at Radboud University Medical Center (Nijmegen, Netherlands) have developed a method using a miniature camera inside coronary arteries to capture high-resolution images of vessel walls. This technique, called optical coherence tomography (OCT), employs near-infrared light to visualize the artery at microscopic detail. While OCT is already used to guide stent placement and reduce complications, physicians typically assess only the infarction site. By adding AI analysis, entire arteries can now be mapped for vulnerabilities.

In a study of 438 patients, arteries were examined using OCT and analyzed with a newly developed AI, with follow-up over two years. The AI detected vulnerable arterial spots as accurately as international gold-standard labs, but also predicted recurrent infarctions or death within two years more effectively. The study, published in the European Heart Journal, demonstrates that AI can reliably handle the large volume of images produced by OCT scans, surpassing manual interpretation limits.

By identifying high-risk plaques and their exact locations, physicians may one day tailor medication or place preventive stents before another heart attack occurs. The study suggests AI could transform OCT from a localized diagnostic tool into a comprehensive method for predicting cardiovascular risk. Researchers expect it will take several years before this approach is integrated into routine clinical practice, but the potential to improve patient outcomes is significant.

“This technique is already used in clinical practice to guide angioplasty and to check whether a stent has been placed correctly”, said Jos Thannhauser, lead investigator of the study. “It has been shown that OCT reduces the risk of new infarctions and complications. But in those cases, physicians only look at a very small part of an artery—the site of the infarction. Our study shows that this technique, combined with AI, has much greater potential to map entire vessels.”

Related Links:
Radboud University Medical Center


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.